Adial pharmaceuticals to present at the h.c. wainwright 25th annual global investment conference

Charlottesville, va., sept. 05, 2023 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil; adilw) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that cary claiborne, ceo of adial pharmaceuticals, will be participating in the h.c. wainwright 25th annual global investment conference being held september 11-13, 2023 at the lotte new york palace hotel in new york city.
ADIL Ratings Summary
ADIL Quant Ranking